IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of…

By Dr. Matthew Watson

Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025 - May 26th, 2025
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - May 26th, 2025
Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 - May 26th, 2025
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting - May 26th, 2025
Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2 - May 26th, 2025
CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer - May 26th, 2025
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd. - May 26th, 2025
Boundless Bio Announces Portfolio Prioritization and Runway Extension - May 26th, 2025
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year;... - May 26th, 2025
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - May 26th, 2025
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - May 26th, 2025
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q - May 26th, 2025
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - May 26th, 2025
IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules - May 26th, 2025
Polyrizon Announces Receipt of Nasdaq Delisting Notice - May 26th, 2025
Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant... - May 26th, 2025
ZLNA – Issuance of shares through set-off of option exercise fee - May 26th, 2025
Guerbet : Changes in the composition of the Guerbet board of directors. - May 26th, 2025
Chair of Sernova Biotherapeutics Resigns - May 26th, 2025
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting - May 18th, 2025
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference - May 18th, 2025
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day - May 18th, 2025
Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates - May 18th, 2025
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award - May 18th, 2025
PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025 - May 18th, 2025
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study - May 18th, 2025
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform - May 18th, 2025
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - May 18th, 2025
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement - May 18th, 2025
Transactions of Managers and Closely Associated Persons - May 18th, 2025
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase - May 18th, 2025
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the... - May 18th, 2025
TestoPrime Reviews Side Effects (INVESTIGATED) Is This Testosterone Booster Safe? (Ingredients, Results & Where to Buy) - May 18th, 2025
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer - May 18th, 2025
75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition - May 18th, 2025
Alvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on Nasdaq Stockholm - May 18th, 2025
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - May 18th, 2025
Tessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene Writing™ Programs and Delivery Platform at the... - May 18th, 2025
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF... - May 18th, 2025
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025 - May 6th, 2025
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates - May 6th, 2025
uniQure to Announce First Quarter 2025 Financial Results - May 6th, 2025
Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights - May 6th, 2025
Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025 - May 6th, 2025
FibroGen to Report First Quarter 2025 Financial Results - May 6th, 2025
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates - May 6th, 2025
Context Therapeutics Announces Chief Medical Officer Transition - May 6th, 2025
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - May 6th, 2025
Certara Reports First Quarter 2025 Financial Results - May 6th, 2025
Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update - May 6th, 2025
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - May 6th, 2025
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET - May 6th, 2025
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of... - May 6th, 2025
Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company - May 6th, 2025
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with... - May 6th, 2025
argenx to Present at BofA Securities 2025 Health Care Conference - May 6th, 2025
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity - May 6th, 2025
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy - May 6th, 2025
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation - May 6th, 2025
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa - April 23rd, 2025
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala - April 23rd, 2025
Cambridge’s DIOSynVax and Singapore’s ACM Biolabs to Advance Pandemic-Ready Universal Bird Flu Vaccine with International Support - April 23rd, 2025
NewGen Filed 2024 Annual Report on Form 20-F - April 23rd, 2025
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - April 23rd, 2025
Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in Stockholm - April 23rd, 2025
Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research - April 23rd, 2025
Andrew Taylor joins Novonesis’ Executive Leadership Team - April 23rd, 2025
Sirona Biochem Announces Debenture Financing - April 23rd, 2025
Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - April 23rd, 2025
Digicann Ventures Provides Update Regarding Proposed RTO Transaction - April 23rd, 2025
Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe... - April 23rd, 2025
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones - April 23rd, 2025
Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025 - April 23rd, 2025
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - April 23rd, 2025
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into... - April 23rd, 2025
OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and... - April 23rd, 2025
Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS) - April 23rd, 2025
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - April 23rd, 2025
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a... - April 23rd, 2025
Preliminary Results for the Year Ended 31 December 2024 - April 14th, 2025

Global News Feed commento

Comments Off | data

May 26th, 2025

About... Dr. Matthew Watson

This author published 6232 posts in this site.

Comments are closed.

Previous post - Next post

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of…

By Dr. Matthew Watson

About... Dr. Matthew Watson

Share

Comments are closed.

Categories

Archives

Recommended Sites